What is NDC 68308-685?

68308-685 is the product NDC for tazarotene, Tazarotene 1 mg/g aerosol, foam, listed with the FDA by Mayne Pharma Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Mayne Pharma Inc., NDC labeler code 68308. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for tazarotene?

14 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

tazarotene NDC 68308-685 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68308-685Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68308-0685Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68308-685-50	6830806855068308068550	1 CAN in 1 CARTON (68308-685-50) / 50 g in 1 CANMarketed from Apr 23, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): tazarotene
Generic name (nonproprietary): tazarotene
Active ingredients: Tazarotene — 1 mg/g
Dosage form: Aerosol, Foam
Route: Topical
Labeler: Mayne Pharma Inc.NDC labeler code 68308
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 202428
Marketing start: Apr 23, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 68308-685_6096a6e0-932a-4eb2-a15a-4fb7b2cd8f67SPL ID 6096a6e0-932a-4eb2-a15a-4fb7b2cd8f67SPL set ID 0e337598-f589-483f-a2ae-be7c319d7454RxCUI 1293451UNII 81BDR9Y8PS
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468308068550 followed by a unit qualifier and the quantity

Package 68308-0685-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 4, 2024.

Indications (excerpt from the label)

Tazarotene Foam, 0.1% is indicated for the topical treatment of acne vulgaris in patients 12 years of age or older. Tazarotene Foam is a retinoid indicated for the topical treatment of acne vulgaris in patients 12 years of age or older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68308-685

What is NDC 68308-685?: 68308-685 is the product NDC for tazarotene, Tazarotene 1 mg/g aerosol, foam, listed with the FDA by Mayne Pharma Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: tazarotene.
What is the active ingredient?: Tazarotene.
Who is the labeler?: Mayne Pharma Inc., NDC labeler code 68308. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for tazarotene?: 14 other product NDCs are listed under this name. See all tazarotene NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other tazarotene NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tazarotene	Tazarotene .5 mg/g	CreamTopical	Cosette Pharmaceuticals, Inc.	0713-0765	00713-0765-3100713-0765-60
Tazarotene	Tazarotene .5 mg/g	GelCutaneous	Solaris Pharma Corporation	73473-309	73473-0309-1073473-0309-30
Tazarotene	Tazarotene 1 mg/g	GelCutaneous	Solaris Pharma Corporation	73473-310	73473-0310-1073473-0310-30
Tazarotene	Tazarotene .5 mg/g	CreamTopical	Padagis Israel Pharmaceuticals Ltd	45802-706	45802-0706-9445802-0706-96
Tazarotene	Tazarotene .5 mg/g	CreamTopical	Bryant Ranch Prepack	72162-2420	72162-2420-0372162-2420-06
Tazarotene	Tazarotene .5 mg/g	GelTopical	Padagis Israel Pharmaceuticals Ltd	45802-436	45802-0436-0145802-0436-94
Tazarotene	Tazarotene 1 mg/g	GelTopical	Padagis Israel Pharmaceuticals Ltd	45802-442	45802-0442-0145802-0442-94
Tazarotene	Tazarotene 1 mg/g	GelTopical	Bryant Ranch Prepack	72162-2202	72162-2202-03
Tazarotene	Tazarotene 1 mg/g	GelTopical	Cosette Pharmaceuticals, Inc.	0713-0804	00713-0804-3100713-0804-99
Tazarotene	Tazarotene .5 mg/g	GelTopical	Cosette Pharmaceuticals, Inc.	0713-0805	00713-0805-3100713-0805-99

All 15 tazarotene NDCs

Other NDCs under NDA 202428

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 202428
Product	Strength	Form · route	Labeler	Product NDC
Fabiortazarotene	Tazarotene 1 mg/g	Aerosol, FoamTopical	Mayne Pharma	51862-295